3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
31
Burkitt Lymphoma
12
Recurrence
11
Lung Neoplasms
11
Leukemia, Myeloid, Acute
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Non-Hodgkin
8
Hodgkin Disease
8
Carcinoma, Non-Small-Cell Lung
7
Neuroblastoma
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Lymphoma, B-Cell
4
Leukemia
4
Wilms Tumor
3
Sarcoma, Ewing
3
Plasmablastic Lymphoma
3
Neoplasms, Germ Cell and Embryonal
3
Neoplasms
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, T-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Immunoblastic Lymphadenopathy
3
Ganglioneuroblastoma
3
Waldenstrom Macroglobulinemia
2
Interventions
pasireotide
1
lutetium Lu 177 dotatate
1
lanreotide
1
amino-acid, glucose, and electrolyte solution
1
Sunitinib
1
Octreotide
1
Everolimus
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Etoposide
×
90 days
×
Clear all
No trials found.